ARRAY MANAGEMENT, LLC – Trademark Portfolio

Entity Type: 16

ARRAY MANAGEMENT, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 8 filings in this category. Currently, 7 trademarks are registered. Notable registered marks include ARRAY SKIN THERAPY, OUR LIGHT. YOUR SHINE., THE WAY LIGHT THERAPY SHOULD BE, and ARRAY SKIN THERAPY PSORIASIS AND VITILIGO TREATMENT CENTERS. The owner is based in Mission Viejo, CA.

26932 Oso Pkwy #270

Mission Viejo, CA 92691

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ARRAY MANAGEMENT, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (8 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ARRAY MANAGEMENT, LLC have?

ARRAY MANAGEMENT, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 7 registered, 1 abandoned.

What trademark classes does ARRAY MANAGEMENT, LLC file in?

ARRAY MANAGEMENT, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are ARRAY MANAGEMENT, LLC's most well-known trademarks?

ARRAY MANAGEMENT, LLC's registered trademark portfolio includes well-known marks such as ARRAY SKIN THERAPY, OUR LIGHT. YOUR SHINE., THE WAY LIGHT THERAPY SHOULD BE, and ARRAY SKIN THERAPY PSORIASIS AND VITILIGO TREATMENT CENTERS. These are among 7 currently registered trademarks in the portfolio.

What is ARRAY MANAGEMENT, LLC's trademark registration success rate?

ARRAY MANAGEMENT, LLC has a 88% trademark registration rate, with 7 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.